FEC Mobilized Stem Cells for High-dose Therapy in Breast Cancer Patients

By Lindman Henrik   Wiklund Tom   Holte Harald   Ljungman Per   Blomqvist Carl   Kvalheim Gunnar   Bengtsson Mats   Höglund Martin   Wilking Nils   Bergh Jonas  

Acta Oncologica, Vol. 38, Iss. 2, 1999-03 ,pp. : 239-245

Informa Healthcare

Access to resources Recommend Favorite

Treatment with Formestane Alone and in Combination with Aminoglutethimide in Heavily Pretreated Breast Cancer Patients: Clinical and Endocrine Effects

By Geisler J.   Johannessen D.C.   Anker G.   Lonning P.E.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 789-792

Elsevier

Access to resources Recommend Favorite

Estrogen and estrogen–progestin replacement therapy and risk of postmenopausal breast cancer in Canada

By Kirsh V.  

Cancer Causes and Control, Vol. 13, Iss. 6, 2002-08 ,pp. : 583-590

Springer Publishing Company

Access to resources Recommend Favorite

Paclitaxel-containing High-dose Chemotherapy in High-risk Breast Cancer Patients

By Greinix Hildegard T.   Linkesch Werner   Seifert Manfred   Kubista Ernst   Czerwenka Klaus   Elahi Fariborz   Zielinski Christoph   Hoecker Paul   Steger Günther   Schulenburg Axel   Neumeister Geralt   Rabitsch Werner   Jakesz Raimund   Kalhs Peter  

Acta Oncologica, Vol. 39, Iss. 1, 2000-04 ,pp. : 47-52

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept

By Iwata Hiroji  

Breast Cancer, Vol. 18, Iss. 2, 2011-04 ,pp. : 92-97

Springer Publishing Company

Access to resources Recommend Favorite